Habil, Jalil H.
HRN: 16-68-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2022
CEFTRIAXONE 1G (VIAL)
11/02/2022
11/08/2022
IVT
2gms
Od
UTI; R/o Dengue Fever; R/o Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes